Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

PCN Insights, News, Videos, and More

Videos
Real-World Data Deep Dive: Viloxazine ER Compared With Atomoxetine for ADHD Study
12/12/2023
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann explore key findings from the real-world study comparing viloxazine ER with atomoxetine for ADHD treatment in adult and...
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann explore key findings from the real-world study comparing viloxazine ER with atomoxetine for ADHD treatment in adult and...
In this roundtable discussion...
12/12/2023
Psych Congress Network
Female Soldier or Veteran
News
Pharmacotherapy Suboptimal After Schizophrenia Diagnosis in VHA System
12/12/2023
Julie Gould
Study indicates deficiencies in pharmacotherapy practices following schizophrenia diagnosis and underscores the substantial impact of the condition on veterans' hospitalization rates, health care resource utilization (HRU), and associated...
Study indicates deficiencies in pharmacotherapy practices following schizophrenia diagnosis and underscores the substantial impact of the condition on veterans' hospitalization rates, health care resource utilization (HRU), and associated...
Study indicates deficiencies in...
12/12/2023
Psych Congress Network
News
Use of Psilocbyin in Bipolar II Treatment Clinical Trial Produces Strong Results
12/12/2023
Tom Valentino, Digital Managing Editor
In a recent trial conducted by Sheppard Pratt researchers, 80% of participants with treatment-resistant bipolar II met the criteria for remission 12 weeks after treatment that included psilocybin and therapy.
In a recent trial conducted by Sheppard Pratt researchers, 80% of participants with treatment-resistant bipolar II met the criteria for remission 12 weeks after treatment that included psilocybin and therapy.
In a recent trial conducted by...
12/12/2023
Psych Congress Network
News
In MS, Patients With Central Neuropathic Pain Carry Highest Emotional Burden
12/11/2023
Jolynn Tumolo
Emotional burden and pain severity were greater in patients with multiple sclerosis (MS) who had central neuropathic pain than those who had musculoskeletal pain.
Emotional burden and pain severity were greater in patients with multiple sclerosis (MS) who had central neuropathic pain than those who had musculoskeletal pain.
Emotional burden and pain...
12/11/2023
Neurology
Evolution
News
Leading Psychotherapy Conference Returns to Anaheim for the First Time Since 2017
12/08/2023
Meagan Thistle
HMP Global's 2023 Evolution of Psychotherapy conference is set to provide an enriching 5-day educational experience for psychotherapy and mental health care professionals.
HMP Global's 2023 Evolution of Psychotherapy conference is set to provide an enriching 5-day educational experience for psychotherapy and mental health care professionals.
HMP Global's 2023 Evolution of...
12/08/2023
Psychiatry & Behavioral Health
Dr Julie Carbray
Videos
The Gold Standard: Using Mood Stabilizers in the Treatment of Bipolar Disorder
12/07/2023

With Julie Carbray, PhD

With Julie Carbray, PhD
Dr Julie Carbray discusses why lithium is considered the gold standard mood stabilizer and when SGA monotherapy should be avoided in treatment.
Dr Julie Carbray discusses why lithium is considered the gold standard mood stabilizer and when SGA monotherapy should be avoided in treatment.
Dr Julie Carbray discusses why...
12/07/2023
Psych Congress Network
Neuroactive Nasal Spray Promising Treatment for SAD
News
Neuroactive Nasal Spray Promising Treatment for SAD
12/07/2023
Evi Arthur
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a...
12/07/2023
Psych Congress Network
brain and pills
News
Esketamine Nasal Spray Combination Therapy Outperforms Quetiapine in TRD Treatment
12/07/2023
Meagan Thistle
The combination of esketamine nasal spray plus an SSRI or an SNRI has emerged as a superior treatment option for TRD, compared to extended-release quetiapine plus an SSRI or SNRI.
The combination of esketamine nasal spray plus an SSRI or an SNRI has emerged as a superior treatment option for TRD, compared to extended-release quetiapine plus an SSRI or SNRI.
The combination of esketamine...
12/07/2023
Psych Congress Network
Amber Hoberg, MSN, APRN, PMHNP-BC, Jonathan Meyer, MD, and Saundra Jain, PsyD
Podcasts
Your Questions Answered: Optimizing Tardive Dyskinesia Care
12/05/2023

Featuring Amber Hoberg, MSN, APRN, PMHNP-BC; Jonathan Meyer, MD; and Saundra Jain, MA, PsyD, LPC

Featuring Amber Hoberg, MSN, APRN, PM...
Clinical experts Amber Hoberg, MSN, APRN, PMHNP-BC, and Jonathan Meyer, MD, answer audience questions on their session, "More than Skin Deep: Examining the Full Impact of Tardive Dyskinesia," presented at Psych Congress Regionals.
Clinical experts Amber Hoberg, MSN, APRN, PMHNP-BC, and Jonathan Meyer, MD, answer audience questions on their session, "More than Skin Deep: Examining the Full Impact of Tardive Dyskinesia," presented at Psych Congress Regionals.
Clinical experts Amber Hoberg,...
12/05/2023
Psych Congress Network
a woman struggles to sleep
News
Genetic Predisposition for Short Sleep Linked With Future Depression Onset
12/05/2023
Jolynn Tumolo
A genetic predisposition to sleeping fewer than 5 hours a night was strongly associated with depression onset over an average 8 years of follow-up in adults 50 years and older, according to a study published in Translational Psychiatry.
A genetic predisposition to sleeping fewer than 5 hours a night was strongly associated with depression onset over an average 8 years of follow-up in adults 50 years and older, according to a study published in Translational Psychiatry.
A genetic predisposition to...
12/05/2023
Neurology

Advertisement

Advertisement

Recent Quizzes

pop quiz
Quiz
Esketamine Dosing Schedule for Treatment-Resistant Depression
10/01/2024
During the induction and maintenance phases of esketamine treatment, how frequently should the medication be administered to treat TRD? Take the quiz to test your psychopharmacology knowledge.
During the induction and maintenance phases of esketamine treatment, how frequently should the medication be administered to treat TRD? Take the quiz to test your psychopharmacology knowledge.
During the induction and...
10/01/2024
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Telehealth Versus In-Person Psychiatric Care
09/19/2024
Do you know what the data from randomized control trials say?
Do you know what the data from randomized control trials say?
Do you know what the data from...
09/19/2024
Psych Congress Network
How many ADHD prescriptions are affected by the med shortage?
Quiz
How many ADHD prescriptions are affected by the med shortage?
09/17/2024
Take a quick poll on your recent prescribing practices!
Take a quick poll on your recent prescribing practices!
Take a quick poll on your recent...
09/17/2024
Psych Congress Network
Symptom Reduction in Bipolar Disorder Treatment
Expert Insights Quiz
Symptom Reduction in Bipolar Disorder Treatment
09/13/2024
Test your knowledge
Test your knowledge
Test your knowledge
09/13/2024
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
CDC/AAP Treatment Guidelines for Pediatric ADHD
09/11/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
09/11/2024
Psych Congress Network
A person completes a puzzle of a profile of a head, with a piece missing from where the brain is located.
Quiz
Considerations When Prescribing Deutetrabenazine for Tardive Dyskinesia
09/10/2024
Put your clinical knowledge to the test with this quiz!
Put your clinical knowledge to the test with this quiz!
Put your clinical knowledge to...
09/10/2024
Psych Congress Network
A person completes a puzzle of a profile of a head, with a piece missing from where the brain is located.
Quiz
Considerations When Prescribing Deutetrabenazine for Tardive Dyskinesia
09/10/2024
Put your clinical knowledge to the test with this quiz!
Put your clinical knowledge to the test with this quiz!
Put your clinical knowledge to...
09/10/2024
Psych Congress Network
brain puzzle graphic
Quiz
Treatment Guidelines for Patients With MDD Who Have Not Responded to Current Pharmacotherapy
09/09/2024
Patients with MDD who have undergone an adequate trial of optimized pharmacotherapy but only partial or no response should be reassessed for what? Take the quiz to find out!
Patients with MDD who have undergone an adequate trial of optimized pharmacotherapy but only partial or no response should be reassessed for what? Take the quiz to find out!
Patients with MDD who have...
09/09/2024
Psych Congress Network
quiz
Quiz
What is the "most underutilized medication" in bipolar disorder treatment?
08/12/2024
Do you remember this interview with Dr Jain?
Do you remember this interview with Dr Jain?
Do you remember this interview...
08/12/2024
Psych Congress Network
By how much did AKL-T01 improve focus in adults with ADHD?
Quiz
By how much did AKL-T01 improve focus in adults with ADHD?
08/12/2024
Pop quiz!
Pop quiz!
Pop quiz!
08/12/2024
Psych Congress Network

Newsletter Signup

Psych Congress Network Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement